Skip to main content
. 2020 Jun 16;51(7):2066–2075. doi: 10.1161/STROKEAHA.120.028825

Figure 1.

Figure 1.

Selection of the study population. The percentages of patients who initiated vitamin K antagonists (VKAs), apixaban, rivaroxaban, and dabigatran were reported based on the number of oral anticoagulant (OAC)-naive patients (n=321 501). AF indicates atrial fibrillation.